TY - JOUR AU - Wee, J. T. AU - Ha, T. C. AU - Loong, S. L. AU - Qian, C. N. PY - 2010 DA - 2010// TI - Is nasopharyngeal cancer really a "Cantonese cancer"? JO - Chin J Cancer VL - 29 UR - https://doi.org/10.5732/cjc.009.10329 DO - 10.5732/cjc.009.10329 ID - Wee2010 ER - TY - JOUR AU - Choa, G. PY - 1967 DA - 1967// TI - Nasopharyngeal carcinoma. Some observations on the clinical features and technique of examination JO - Pac Med Surg VL - 75 ID - Choa1967 ER - TY - JOUR AU - Peng, G. AU - Wang, T. AU - Yang, K. Y. AU - Zhang, S. AU - Zhang, T. AU - Li, Q. AU - Han, J. AU - Wu, G. PY - 2012 DA - 2012// TI - A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma JO - Radiother Oncol VL - 104 UR - https://doi.org/10.1016/j.radonc.2012.08.013 DO - 10.1016/j.radonc.2012.08.013 ID - Peng2012 ER - TY - JOUR AU - Zhang, M. X. AU - Li, J. AU - Shen, G. P. AU - Zou, X. AU - Xu, J. J. AU - Jiang, R. AU - You, R. AU - Hua, Y. J. AU - Sun, Y. AU - Ma, J. PY - 2015 DA - 2015// TI - Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up JO - Eur J Cancer VL - 51 UR - https://doi.org/10.1016/j.ejca.2015.08.006 DO - 10.1016/j.ejca.2015.08.006 ID - Zhang2015 ER - TY - JOUR AU - Lee, N. AU - Xia, P. AU - Quivey, J. M. AU - Sultanem, K. AU - Poon, I. AU - Akazawa, C. AU - Akazawa, P. AU - Weinberg, V. AU - Fu, K. K. PY - 2002 DA - 2002// TI - Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience JO - Int J Radiat Oncol Biol Phys VL - 53 UR - https://doi.org/10.1016/S0360-3016(02)02724-4 DO - 10.1016/S0360-3016(02)02724-4 ID - Lee2002 ER - TY - JOUR AU - Sun, X. AU - Su, S. AU - Chen, C. AU - Han, F. AU - Zhao, C. AU - Xiao, W. AU - Deng, X. AU - Huang, S. AU - Lin, C. AU - Lu, T. PY - 2014 DA - 2014// TI - Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities JO - Radiother Oncology VL - 110 UR - https://doi.org/10.1016/j.radonc.2013.10.020 DO - 10.1016/j.radonc.2013.10.020 ID - Sun2014 ER - TY - JOUR AU - Hong, R. L. AU - Ting, L. L. AU - Ko, J. Y. AU - Hsu, M. M. AU - Sheen, T. S. AU - Lou, P. J. AU - Wang, C. C. AU - Chung, N. N. AU - Lui, L. T. PY - 2001 DA - 2001// TI - Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma JO - J Clin Oncol VL - 19 UR - https://doi.org/10.1200/JCO.2001.19.23.4305 DO - 10.1200/JCO.2001.19.23.4305 ID - Hong2001 ER - TY - JOUR AU - Hui, E. P. AU - Ma, B. B. AU - Leung, S. F. AU - King, A. D. AU - Mo, F. AU - Kam, M. K. AU - Yu, B. K. AU - Chiu, S. K. AU - Kwan, W. H. AU - Ho, R. PY - 2009 DA - 2009// TI - Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.1545 DO - 10.1200/JCO.2008.18.1545 ID - Hui2009 ER - TY - JOUR AU - Bossi, P. AU - Orlandi, E. AU - Bergamini, C. AU - Locati, L. D. AU - Granata, R. AU - Mirabile, A. AU - Parolini, D. AU - Franceschini, M. AU - Fallai, C. AU - Olmi, P. PY - 2011 DA - 2011// TI - Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer JO - Ann Oncol Med Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdq783 DO - 10.1093/annonc/mdq783 ID - Bossi2011 ER - TY - JOUR AU - Chen, J. AU - Qi, J. AU - Yu, B. AU - Peng, X. H. AU - Wang, F. AU - Tan, J. J. AU - Chen, Q. Q. AU - Peng, X. Y. AU - Zeng, F. F. AU - Liu, X. PY - 2018 DA - 2018// TI - A retrospective study to compare five induction chemotherapy regimens prior to radiotherapy in the reduction of regional lymph node size in patients with nasopharyngeal carcinoma JO - Med Sci Mon VL - 24 UR - https://doi.org/10.12659/MSM.906625 DO - 10.12659/MSM.906625 ID - Chen2018 ER - TY - JOUR AU - Liu, G. Y. AU - Lv, X. AU - Wu, Y. S. AU - Mao, M. J. AU - Ye, Y. F. AU - Yu, Y. H. AU - Liang, H. AU - Yang, J. AU - Ke, L. R. AU - Qiu, W. Z. PY - 2018 DA - 2018// TI - Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis JO - Cancer Commun (London, England) VL - 38 UR - https://doi.org/10.1186/s40880-018-0283-2 DO - 10.1186/s40880-018-0283-2 ID - Liu2018 ER - TY - JOUR AU - Peng, H. AU - Tang, L. L. AU - Chen, B. B. AU - Chen, L. AU - Li, W. F. AU - Mao, Y. P. AU - Liu, X. AU - Zhang, Y. AU - Liu, L. Z. AU - Tian, L. PY - 2018 DA - 2018// TI - Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal carcinoma: a big-data intelligence platform-based analysis JO - Oral Oncol VL - 79 UR - https://doi.org/10.1016/j.oraloncology.2018.02.011 DO - 10.1016/j.oraloncology.2018.02.011 ID - Peng2018 ER - TY - JOUR AU - Colevas, A. D. AU - Posner, M. R. PY - 1998 DA - 1998// TI - Docetaxel in head and neck cancer: a review JO - Am J Clin Oncol VL - 21 UR - https://doi.org/10.1097/00000421-199810000-00013 DO - 10.1097/00000421-199810000-00013 ID - Colevas1998 ER - TY - JOUR AU - Verweij, J. AU - Clavel, M. AU - Chevalier, B. PY - 1994 DA - 1994// TI - Paclitaxel (TaxolTM) and docetaxel (TaxotereTM): not simply two of a kind JO - Ann Oncol VL - 5 UR - https://doi.org/10.1093/oxfordjournals.annonc.a058903 DO - 10.1093/oxfordjournals.annonc.a058903 ID - Verweij1994 ER - TY - JOUR AU - Kelly, C. M. AU - Green, M. C. AU - Broglio, K. AU - Thomas, E. S. AU - Brewster, A. M. AU - Valero, V. AU - Ibrahim, N. K. AU - Gonzalez-Angulo, A. M. AU - Booser, D. J. AU - Walters, R. S. PY - 2012 DA - 2012// TI - Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.36.2079 DO - 10.1200/JCO.2011.36.2079 ID - Kelly2012 ER - TY - JOUR AU - Sharma, N. K. AU - Kumar, V. PY - 2015 DA - 2015// TI - Liposomal paclitaxel: recent trends and future perspectives JO - Int J Pharm Sci Rev Res VL - 31 ID - Sharma2015 ER - TY - JOUR AU - Yang, T. AU - Cui, F. -. D. AU - Choi, M. -. K. AU - Lin, H. AU - Chung, S. -. J. AU - Shim, C. -. K. AU - Kim, D. -. D. PY - 2007 DA - 2007// TI - Liposome formulation of paclitaxel with enhanced solubility and stability JO - Drug Delivery VL - 14 UR - https://doi.org/10.1080/10717540601098799 DO - 10.1080/10717540601098799 ID - Yang2007 ER - TY - JOUR AU - Xu, X. AU - Wang, L. AU - Xu, H. -. Q. AU - Huang, X. -. E. AU - Qian, Y. -. D. AU - Xiang, J. PY - 2013 DA - 2013// TI - Clinical comparison between paclitaxel liposome (LipusuĀ®) and paclitaxel for treatment of patients with metastatic gastric cancer JO - Asian Pac J Cancer Prev VL - 14 UR - https://doi.org/10.7314/APJCP.2013.14.4.2591 DO - 10.7314/APJCP.2013.14.4.2591 ID - Xu2013 ER - TY - JOUR AU - Al-Sarraf, M. AU - LeBlanc, M. AU - Giri, P. G. AU - Fu, K. K. AU - Cooper, J. AU - Vuong, T. AU - Forastiere, A. A. AU - Adams, G. AU - Sakr, W. A. AU - Schuller, D. E. PY - 1998 DA - 1998// TI - Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099 JO - J Clin Oncol VL - 16 UR - https://doi.org/10.1200/JCO.1998.16.4.1310 DO - 10.1200/JCO.1998.16.4.1310 ID - Al-Sarraf1998 ER - TY - JOUR AU - Lee, A. W. AU - Ngan, R. K. AU - Tung, S. Y. AU - Cheng, A. AU - Kwong, D. L. AU - Lu, T. X. AU - Chan, A. T. AU - Chan, L. L. AU - Yiu, H. AU - Ng, W. T. PY - 2015 DA - 2015// TI - Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma JO - Cancer VL - 121 UR - https://doi.org/10.1002/cncr.29208 DO - 10.1002/cncr.29208 ID - Lee2015 ER - TY - JOUR AU - Lee, A. AU - Lau, K. AU - Hung, W. AU - Ng, W. AU - Lee, M. AU - Choi, C. AU - Chan, C. AU - Tung, R. AU - Cheng, P. AU - Yau, T. PY - 2008 DA - 2008// TI - Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma JO - Radiother Oncol VL - 87 UR - https://doi.org/10.1016/j.radonc.2008.02.003 DO - 10.1016/j.radonc.2008.02.003 ID - Lee2008 ER - TY - JOUR AU - Lin, S. AU - Lu, J. J. AU - Han, L. AU - Chen, Q. AU - Pan, J. PY - 2010 DA - 2010// TI - Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-39 DO - 10.1186/1471-2407-10-39 ID - Lin2010 ER - TY - JOUR AU - Yu, Z. AU - Luo, W. AU - Zhou, Q. C. AU - Zhang, Q. H. AU - Kang, D. H. AU - Liu, M. Z. PY - 2009 DA - 2009// TI - Impact of changing gross tumor volume delineation of intensity-modulated radiotherapy on the dose distribution and clinical treatment outcome after induction chemotherapy for the primary locoregionally advanced nasopharyngeal carcinoma JO - Ai zheng = Aizheng = Chinese journal of cancer VL - 28 UR - https://doi.org/10.5732/cjc.009.10435 DO - 10.5732/cjc.009.10435 ID - Yu2009 ER - TY - STD TI - Kampan NC, Madondo MT, McNally OM, Quinn M, Plebanski M: Paclitaxel and its evolving role in the Management of Ovarian Cancer. Biomed Res Int 2015, 2015:413076. ID - ref24 ER - TY - JOUR AU - Rowinsky, E. K. AU - Donehower, R. C. PY - 1995 DA - 1995// TI - Paclitaxel (taxol) JO - N Engl J Med VL - 332 UR - https://doi.org/10.1056/NEJM199504133321507 DO - 10.1056/NEJM199504133321507 ID - Rowinsky1995 ER - TY - JOUR AU - Goldspiel, B. R. PY - 1997 DA - 1997// TI - Clinical overview of the taxanes JO - Pharmacotherapy VL - 17 ID - Goldspiel1997 ER - TY - JOUR AU - Crown, J. AU - O'Leary, M. PY - 2000 DA - 2000// TI - The taxanes: an update JO - Lancet (London, England) VL - 355 UR - https://doi.org/10.1016/S0140-6736(00)02074-2 DO - 10.1016/S0140-6736(00)02074-2 ID - Crown2000 ER - TY - JOUR AU - Nehate, C. AU - Jain, S. AU - Saneja, A. AU - Khare, V. AU - Alam, N. AU - Dubey, R. D. AU - Gupta, P. N. PY - 2014 DA - 2014// TI - Paclitaxel formulations: challenges and novel delivery options JO - Curr Drug Deliv VL - 11 UR - https://doi.org/10.2174/1567201811666140609154949 DO - 10.2174/1567201811666140609154949 ID - Nehate2014 ER - TY - JOUR AU - Posner, M. R. AU - Hershock, D. M. AU - Blajman, C. R. AU - Mickiewicz, E. AU - Winquist, E. AU - Gorbounova, V. AU - Tjulandin, S. AU - Shin, D. M. AU - Cullen, K. AU - Ervin, T. J. PY - 2007 DA - 2007// TI - Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa070956 DO - 10.1056/NEJMoa070956 ID - Posner2007 ER - TY - JOUR AU - Vermorken, J. B. AU - Remenar, E. AU - Herpen, C. AU - Gorlia, T. AU - Mesia, R. AU - Degardin, M. AU - Stewart, J. S. AU - Jelic, S. AU - Betka, J. AU - Preiss, J. H. PY - 2007 DA - 2007// TI - Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa071028 DO - 10.1056/NEJMoa071028 ID - Vermorken2007 ER - TY - JOUR AU - Lorch, J. H. AU - Goloubeva, O. AU - Haddad, R. I. AU - Cullen, K. AU - Sarlis, N. AU - Tishler, R. AU - Tan, M. AU - Fasciano, J. AU - Sammartino, D. E. AU - Posner, M. R. PY - 2011 DA - 2011// TI - Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(10)70279-5 DO - 10.1016/S1470-2045(10)70279-5 ID - Lorch2011 ER - TY - JOUR AU - Pointreau, Y. AU - Garaud, P. AU - Chapet, S. AU - Sire, C. AU - Tuchais, C. AU - Tortochaux, J. AU - Faivre, S. AU - Guerrif, S. AU - Alfonsi, M. AU - Calais, G. PY - 2009 DA - 2009// TI - Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp007 DO - 10.1093/jnci/djp007 ID - Pointreau2009 ER - TY - JOUR AU - Sun, Y. AU - Li, W. F. AU - Chen, N. Y. AU - Zhang, N. AU - Hu, G. Q. AU - Xie, F. Y. AU - Sun, Y. AU - Chen, X. Z. AU - Li, J. G. AU - Zhu, X. D. PY - 2016 DA - 2016// TI - Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30410-7 DO - 10.1016/S1470-2045(16)30410-7 ID - Sun2016 ER - TY - JOUR AU - Hong, S. S. AU - Choi, J. Y. AU - Kim, J. O. AU - Lee, M. K. AU - Kim, S. H. AU - Lim, S. J. PY - 2016 DA - 2016// TI - Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation JO - Int J Nanomedicine VL - 11 UR - https://doi.org/10.2147/IJN.S113723 DO - 10.2147/IJN.S113723 ID - Hong2016 ER - TY - JOUR AU - Crosasso, P. AU - Ceruti, M. AU - Brusa, P. AU - Arpicco, S. AU - Dosio, F. AU - Cattel, L. PY - 2000 DA - 2000// TI - Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes JO - J Controlled Release VL - 63 UR - https://doi.org/10.1016/S0168-3659(99)00166-2 DO - 10.1016/S0168-3659(99)00166-2 ID - Crosasso2000 ER - TY - STD TI - Huang ST, Wang YP, Chen YH, Lin CT, Li WS, Wu HC. Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol. Int J Oncol, 1117. 2018;53(3):1105. ID - ref36 ER - TY - JOUR AU - Aoyama, T. AU - Takano, M. AU - Miyamoto, M. AU - Yoshikawa, T. AU - Soyama, H. AU - Kato, K. AU - Ishibashi, H. AU - Iwahashi, H. AU - Nakatsuka, M. AU - Yajima, I. PY - 2017 DA - 2017// TI - Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy? JO - Cancer Chemother Pharmacol VL - 80 UR - https://doi.org/10.1007/s00280-017-3332-7 DO - 10.1007/s00280-017-3332-7 ID - Aoyama2017 ER - TY - JOUR AU - Ratanajarusiri, T. AU - Sriuranpong, V. AU - Sitthideatphaiboon, P. AU - Poovoravan, N. AU - Vinayanuwat, C. AU - Parinyanitikul, N. AU - Angspatt, P. AU - Thawinwisan, W. AU - Tanasanvimon, S. PY - 2017 DA - 2017// TI - A difference in the incidences of hypersensitivity reactions to original and generic Taxanes JO - Chemotherapy VL - 62 UR - https://doi.org/10.1159/000450748 DO - 10.1159/000450748 ID - Ratanajarusiri2017 ER - TY - STD TI - Chen G, Sheng L, Du X. Efficacy and safety of liposome-paclitaxel and carboplatin based concurrent chemoradiotherapy for locally advanced lung squamous cell carcinoma. Cancer Chemother Pharmacol. 2018. ID - ref39 ER - TY - JOUR AU - Zhang, Q. AU - Huang, X. E. AU - Gao, L. L. PY - 2009 DA - 2009// TI - A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors JO - Biomed Pharmacother VL - 63 UR - https://doi.org/10.1016/j.biopha.2008.10.001 DO - 10.1016/j.biopha.2008.10.001 ID - Zhang2009 ER - TY - JOUR AU - Wang, H. Y. AU - Zhang, X. R. PY - 2014 DA - 2014// TI - Comparison of efficacy and safety between liposome-paclitaxel injection plus carboplatin and paclitaxel plus carboplatin as first line treatment in advanced non-small cell lung cancer JO - Zhongguo yi xue ke xue yuan xue bao Acta Academiae Medicinae Sinicae VL - 36 ID - Wang2014 ER - TY - JOUR AU - Wang, R. H. AU - Cao, H. M. AU - Tian, Z. J. AU - Jin, B. AU - Wang, Q. AU - Ma, H. AU - Wu, J. PY - 2015 DA - 2015// TI - Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer JO - Oncol Rep VL - 33 UR - https://doi.org/10.3892/or.2014.3644 DO - 10.3892/or.2014.3644 ID - Wang2015 ER - TY - JOUR AU - Su, W. AU - Zhang, S. AU - Li, C. AU - Hao, X. AU - Zhang, J. PY - 2015 DA - 2015// TI - Efficacy and safety analysis of paclitaxel liposome and docetaxel for the neoadjuvant chemotherapy of breast cancer JO - Zhonghua zhong liu za zhi [Chinese journal of oncology] VL - 37 ID - Su2015 ER - TY - JOUR AU - Lu, M. AU - Wang, T. AU - Wang, J. PY - 2016 DA - 2016// TI - Effects of paclitaxel liposome and capecitabine in the treatment of advanced gastric cancer by clinical observation JO - Int J Clin Pharmacol Ther VL - 54 UR - https://doi.org/10.5414/CP202568 DO - 10.5414/CP202568 ID - Lu2016 ER -